WallStreetZenWallStreetZen

NASDAQ: OPT
Opthea Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OPT

Based on 1 analyst offering 12 month price targets for Opthea Ltd

Min Forecast
$12.00+269.23%
Avg Forecast
$12.00+269.23%
Max Forecast
$12.00+269.23%

Should I buy or sell OPT stock?

Based on 1 analyst offering ratings for Opthea Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OPT stock forecasts and price targets.

OPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-03

1 of 1

Forecast return on equity

Is OPT forecast to generate an efficient return?

Company
-2,433.16%
Industry
139.06%
Market
69.7%
OPT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OPT forecast to generate an efficient return on assets?

Company
977.05%
Industry
22.52%
OPT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OPT earnings per share forecast

What is OPT's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.39
Avg 2 year Forecast
-$0.67
Avg 3 year Forecast
$1.69

OPT revenue forecast

What is OPT's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$213.0k-18.66%
Avg 2 year Forecast
$101.1M+38,520.02%
Avg 3 year Forecast
$399.8M+152,581.4%
OPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OPT revenue growth forecast

How is OPT forecast to perform vs Biotechnology companies and vs the US market?

Company
1,018.94%
Industry
33.54%
Market
8.75%
OPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OPT$3.25$12.00+269.23%Buy
OMER$7.63$9.00+17.96%Strong Buy
KOD$8.47$9.00+6.26%Hold
ABVX$7.11$40.50+469.62%Strong Buy
KRRO$46.88$125.75+168.24%Strong Buy
View Top Biotech Stocks

Opthea Stock Forecast FAQ

Is Opthea Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: OPT) stock is to Buy OPT stock.

Out of 1 analyst, 0 (0%) are recommending OPT as a Strong Buy, 1 (100%) are recommending OPT as a Buy, 0 (0%) are recommending OPT as a Hold, 0 (0%) are recommending OPT as a Sell, and 0 (0%) are recommending OPT as a Strong Sell.

If you're new to stock investing, here's how to buy Opthea stock.

What is OPT's earnings growth forecast for 2025-2027?

(NASDAQ: OPT) Opthea's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.95%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.37%.

Opthea's earnings in 2024 is -$220,242,105.On average, 4 Wall Street analysts forecast OPT's earnings for 2025 to be -$1,517,138,812, with the lowest OPT earnings forecast at -$2,444,885,567, and the highest OPT earnings forecast at -$272,866,693. On average, 4 Wall Street analysts forecast OPT's earnings for 2026 to be -$734,011,403, with the lowest OPT earnings forecast at -$1,746,346,834, and the highest OPT earnings forecast at $174,634,683.

In 2027, OPT is forecast to generate $1,844,578,843 in earnings, with the lowest earnings forecast at -$1,222,442,784 and the highest earnings forecast at $8,469,782,143.

What is OPT's revenue growth forecast for 2025-2027?

(NASDAQ: OPT) Opthea's forecast annual revenue growth rate of 1,018.94% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.75%.

Opthea's revenue in 2024 is $261,859.On average, 3 Wall Street analysts forecast OPT's revenue for 2025 to be $232,482,422, with the lowest OPT revenue forecast at $109,146,677, and the highest OPT revenue forecast at $327,440,031. On average, 3 Wall Street analysts forecast OPT's revenue for 2026 to be $110,380,034,551, with the lowest OPT revenue forecast at $27,286,669,275, and the highest OPT revenue forecast at $268,871,924,368.

In 2027, OPT is forecast to generate $436,379,329,714 in revenue, with the lowest revenue forecast at $81,641,714,471 and the highest revenue forecast at $1,047,502,489,464.

What is OPT's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: OPT) forecast ROA is 977.05%, which is higher than the forecast US Biotechnology industry average of 22.52%.

What is OPT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year OPT price target, the average OPT price target is $12.00, with the highest OPT stock price forecast at $12.00 and the lowest OPT stock price forecast at $12.00.

The Wall Street analyst predicted that Opthea's share price could reach $12.00 by Sep 3, 2025. The average Opthea stock price prediction forecasts a potential upside of 269.23% from the current OPT share price of $3.25.

What is OPT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: OPT) Opthea's current Earnings Per Share (EPS) is -$2.76. On average, analysts forecast that OPT's EPS will be -$1.39 for 2025, with the lowest EPS forecast at -$2.24, and the highest EPS forecast at -$0.25. On average, analysts forecast that OPT's EPS will be -$0.67 for 2026, with the lowest EPS forecast at -$1.60, and the highest EPS forecast at $0.16. In 2027, OPT's EPS is forecast to hit $1.69 (min: -$1.12, max: $7.76).

What is OPT's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: OPT) forecast ROE is -2,433.16%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.